Early effects of acetazolamide on hemoglobin mass and plasma volume in chronic mountain sickness at 5100 m

Introduction and objectives Chronic Mountain Sickness (CMS) syndrome, combining excessive erythrocytosis and clinical symptoms in highlanders, remains a public health concern in high-altitude areas, especially in the Andes, with limited therapeutic approaches. The objectives of this study were to as...

Descrizione completa

Dettagli Bibliografici

Autori principali:	B. Champigneulle, E. Stauffer, P. Robach, S. Doutreleau, C.A. Howe, A. Pina, A.A. Salazar-Granara, I. Hancco, D. Guergour, J.V. Brugniaux, P. Connes, A. Pichon, S. Verges
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2025-12-01
Serie:	Pulmonology
Soggetti:	Chronic mountain sickness Acetazolamide Excessive erythrocytosis Plasma volume Total hemoglobin mass
Accesso online:	https://www.tandfonline.com/doi/10.1016/j.pulmoe.2023.05.006
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!